Maternal Mild Cognitive Impairment during Pregnancy in Relation to Gestational Diabetes Mellitus

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038703

Enrollment

Unknown

Registered

2020-09-29

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GDM

Interventions

P group and G group:blood 3 ml

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-35 years withAmerican Society of Anaesthesiologists(ASA) physical status I – II were admitted to the study

Exclusion criteria

Exclusion criteria: Subjects on medications affecting cognitive functions including corticosteroids, anti-depressants or anti-epileptics were also not included. Additionally, subjects suffering from any chronic metabolic, endocrine, inflammatory or infectious diseases, cancer and subjects who had drug or alcohol dependency, history of major brain abnormalities (e.g. tumors, hydrocephaly), epilepsy, Parkinsons disease or stroke.

Design outcomes

Primary

Measure	Time frame
DPP4;	—

Countries

China

Contacts

Public ContactEn-You Li

The First Affiliated of Harbin Medical University

enyouli@sina.com+86 13845109928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026